Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic

C De la Calle1, H G Ternavasio-de la Vega2, L Morata1

  • 1Department of Infectious Diseases, Hospital Clínic, Barcelona, Spain.

The Journal of Infection
|January 24, 2018
PubMed
Abstract

Insights

Combination antibiotic therapy for bacteraemic pneumococcal pneumonia, using a macrolide or fluoroquinolone with a cephalosporin, significantly reduces 30-day mortality compared to monotherapy. This supports current treatment guidelines for severe pneumonia.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Pharmacology

Background:

  • International guidelines recommend combining macrolides or fluoroquinolones with beta-lactams for moderate to severe community-acquired pneumonia.
  • Limited data exists on combination therapy specifically for bacteraemic pneumococcal pneumonia.

Purpose of the Study:

  • To evaluate the impact of empirical antibiotic therapy on mortality in patients with bacteraemic pneumococcal pneumonia.
  • To compare the outcomes of monotherapy versus combination therapy (cephalosporin plus macrolide or fluoroquinolone).

Main Methods:

  • Propensity score analysis of prospectively collected data from 2000-2015.
  • Inclusion of patients with bacteraemic pneumococcal pneumonia treated with third-generation cephalosporin monotherapy or combination therapy.
  • Comparison of 30-day mortality between monotherapy (n=69) and combination (n=314) groups after propensity score adjustment.

Main Results:

  • Monotherapy was associated with significantly higher 30-day mortality (OR 2.89) after propensity score adjustment.
  • Higher mortality in the monotherapy group was observed in both 1:1 and 1:2 matched samples, statistically significant in the 1:2 sample (OR 3.50).

Conclusions:

  • Empirical combination therapy (third-generation cephalosporin plus macrolide or fluoroquinolone) is associated with lower mortality in bacteraemic pneumococcal pneumonia compared to monotherapy.
  • These findings support the use of combination therapy for hospitalized patients with moderate to severe disease.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.8K
Introduction to z Scores01:06

Introduction to z Scores

A z score (or standardized value) is measured in units of the standard deviation. It tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
11.4K
Introduction to z Scores01:05

Introduction to z Scores

A z score (or standardized value) is measured in units of the standard deviation. It indicates how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
1.4K
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
19.7K